GI
GSK icon

GAMMA Investing’s GSK GSK Stock Holding History

GAMMA Investing’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$592K Buy
12,286
+956
+8% +$48.8K 0.02% 617
2026
Q2 		$594K Buy
11,330
+840
+8% +$44.4K 0.02% 575
2026
Q1 		$579K Buy
10,490
+792
+8% +$42.9K 0.03% 516
2025
Q4 		$476K Buy
9,698
+1,586
+20% +$74K 0.02% 547
2025
Q3 		$350K Buy
8,112
+1,959
+32% +$76.5K 0.02% 641
2025
Q2 		$236K Buy
6,153
+1,706
+38% +$65.2K 0.01% 807
2025
Q1 		$172K Buy
4,447
+2,307
+108% +$84.5K 0.01% 858
2024
Q4 		$72.4K Sell
2,140
-1,161
-35% -$41.8K 0.01% 1357
2024
Q3 		$135K Sell
3,301
-105
-3% -$4.29K 0.01% 812
2024
Q2 		$131K Sell
3,406
-223
-6% -$9.38K 0.02% 651
2024
Q1 		$156K Buy
3,629
+874
+32% +$36K 0.03% 475
2023
Q4 		$109K Buy
+2,755
New +$98.9K 0.03% 511

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

GAMMA Investing's GSK Position: Q3 2026 in Review

GAMMA Investing increased its GSK (GSK) stake by 8.4% in Q3 2026, buying an estimated $48.8K and bringing the position to 12,286 shares worth $592K. The position accounts for 0.02% of the portfolio, ranked #617.

GAMMA Investing first reported a position in GSK in Q4 2023 and has held it in 12 quarters since. The position peaked at $594K in Q2 2026. 31 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • GAMMA Investing held 12,286 shares of GSK worth $592K as of Q3 2026.
  • GAMMA Investing bought 956 GSK shares in Q3 2026, an estimated $48.8K.
  • GSK made up 0.02% of GAMMA Investing's portfolio in Q3 2026, its #617 holding.
  • GAMMA Investing first reported a position in GSK in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's GSK position peaked at $594K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.